APA

Kittlesen D. J., Thompson L. W., Gulden P. H., Skipper J. C., Colella T. A., Shabanowitz J., Hunt D. F., Engelhard V. H., Slingluff C. L. & Shabanowitz J. A. (19980318). Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Kittlesen D J, Thompson L W, Gulden P H, Skipper J C, Colella T A, Shabanowitz J, Hunt D F, Engelhard V H, Slingluff C L and Shabanowitz J A. 19980318. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Kittlesen D. J., Thompson L. W., Gulden P. H., Skipper J. C., Colella T. A., Shabanowitz J., Hunt D. F., Engelhard V. H., Slingluff C. L. and Shabanowitz J. A. (19980318). Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Kittlesen D J, Thompson L W, Gulden P H, Skipper J C, Colella T A, Shabanowitz J, Hunt D F, Engelhard V H, Slingluff C L and Shabanowitz J A. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. : Journal of immunology (Baltimore, Md. : 1950). 19980318.